Newborns and infants may breathe easier with a respiratory-gated, low-dose MSCT imaging technique that depicts the neonatal lung during continuous breathing, according to research presented at the 2004 RSNA meeting.
Newborns and infants may breathe easier with a respiratory-gated, low-dose MSCT imaging technique that depicts the neonatal lung during continuous breathing, according to research presented at the 2004 RSNA meeting.
A study by Dr. Patrik Rogalla and colleagues from Charite Hospital in Berlin examined 20 newborns and infants referred for CT for the following indications:
Respiratory-gating was possible in all examinations.
The researchers used 0.5-mm slice thickness, 10 mAs at 120 kVp, a pitch of 2 to 4.8:16, and 0.4-mm reconstruction intervals for the imaging studies. They measured total volumes for the left and right pulmonary airways during breathing.
While low radiation dose is important for pediatric patients, image quality is imperative for investigating respiratory insufficiencies. The researchers reported that the continuous breathing technique markedly reduced breathing artifacts compared with nongated techniques. Despite the low radiation dose, they were able to calculate volume measurements for all cases.
The technique allowed for in-depth examination of global lung function parameters as well as separate analyses of both lungs and individual lobes, according to the Rogalla.
For more information from the Diagnostic Imaging archives:
Dose concerns limit trauma CT in pediatrics
Low-dose MDCT passes test in acute pain
Italian researchers advocate putting the brakes on x-ray dose
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.